MPG.eBooks - Description: CADTH Canadian Drug Expert Committee recommendation: Dexamethasone (Ozurdex -- Allergan Canada Inc.) indication: for the treatment of adult patients with diabetic macular edema who are pseudophakic

Cover Image

Read Now

CADTH Canadian Drug Expert Committee recommendation: Dexamethasone (Ozurdex -- Allergan Canada Inc.) indication: for the treatment of adult patients with diabetic macular edema who are pseudophakic

The CADTH Canadian Drug Expert Committee (CDEC) recommends that dexamethasone not be reimbursed for the treatment of adult patients with diabetic macular edema (DME) who are pseudophakic

Bibliographic Details
Corporate Authors:	CADTH Canadian Drug Expert Committee, Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) CADTH 2018, October 2018
Edition:	Final
Series:	CADTH common drug review
Subjects:	Canada Diabetes Complications / Drug Therapy Macular Edema / Drug Therapy Intravitreal Injections Pseudophakia Dexamethasone
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK538996
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	The CADTH Canadian Drug Expert Committee (CDEC) recommends that dexamethasone not be reimbursed for the treatment of adult patients with diabetic macular edema (DME) who are pseudophakic
Physical Description:	1 PDF file (8 pages)